Bright Minds Biosciences Inc (DRUG)
Working Capital Ratio
99.16%
Quarterly · Period ending:
DRUG Working Capital Ratio
Latest reported99.16%period ending
Latest reported99.16%period ending
DRUG Quarterly Working Capital Ratio (82.63% → 99.16%)
Quarterly working capital ratio
High-resolution chart · PNG
DRUG working capital ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Working Capital Ratio |
|---|---|
| 99.1632% | |
| 98.7498% | |
| 98.1572% | |
| 97.1011% | |
| 98.6019% | |
| 98.5966% | |
| 98.9066% | |
| 89.4122% | |
| 96.9623% | |
| 86.5878% | |
| 86.8963% | |
| 94.9518% | |
| 90.4814% | |
| 88.9013% | |
| 94.3821% | |
| 86.6687% | |
| 95.6083% | |
| 91.4522% | |
| 96.8104% | |
| 96.8036% | |
| 98.5377% | |
| 98.4024% | |
| 95.5407% | |
| 82.6267% |